Go Pro

VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Competitors

GBX 13.89 0.00 (0.00%)
As of 07/3/2026 10:23 AM Eastern

CYBG vs. CCFS, CIHL, IL0A, FGT, and BGSC

Should you buy VanEck Bionic Engineering UCITS ETF A Acc stock or one of its competitors? MarketBeat compares VanEck Bionic Engineering UCITS ETF A Acc with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with VanEck Bionic Engineering UCITS ETF A Acc include Charter Court Financial Services Grp (CCFS), Caribbean Investment (CIHL), Permanent TSB Group (IL0A), Finsbury Growth & Income (FGT), and BMO Global Smaller Companies (BGSC).

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Charter Court Financial Services Grp?

VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) and Charter Court Financial Services Grp (LON:CCFS) are both small-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, media sentiment, valuation, risk and dividends.

VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Charter Court Financial Services Grp, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VanEck Bionic Engineering UCITS ETF A Acc£1.24B0.16N/A-£7.10N/A
Charter Court Financial Services Grp£221.10M0.00N/A£46.30N/A

VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. Charter Court Financial Services Grp pays an annual dividend of GBX 0.09 per share. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. Charter Court Financial Services Grp pays out 0.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. VanEck Bionic Engineering UCITS ETF A Acc is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, VanEck Bionic Engineering UCITS ETF A Acc's average media sentiment score of 0.00 equaled Charter Court Financial Services Grp'saverage media sentiment score.

Company Net Margins Return on Equity Return on Assets
VanEck Bionic Engineering UCITS ETF A AccN/A N/A N/A
Charter Court Financial Services Grp N/A N/A N/A

Summary

VanEck Bionic Engineering UCITS ETF A Acc beats Charter Court Financial Services Grp on 3 of the 5 factors compared between the two stocks.

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Caribbean Investment?

VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) and Caribbean Investment (LON:CIHL) are both small-cap banks - regional - europe industry companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership.

Company Net Margins Return on Equity Return on Assets
VanEck Bionic Engineering UCITS ETF A AccN/A N/A N/A
Caribbean Investment N/A N/A N/A

VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Caribbean Investment, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VanEck Bionic Engineering UCITS ETF A Acc£1.24B0.16N/A-£7.10N/A
Caribbean Investment£29.20M0.00N/A£8.60N/A

In the previous week, VanEck Bionic Engineering UCITS ETF A Acc's average media sentiment score of 0.00 equaled Caribbean Investment'saverage media sentiment score.

Company Overall Sentiment
VanEck Bionic Engineering UCITS ETF A Acc Neutral
Caribbean Investment Neutral

Summary

Caribbean Investment beats VanEck Bionic Engineering UCITS ETF A Acc on 2 of the 3 factors compared between the two stocks.

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Permanent TSB Group?

Permanent TSB Group (LON:IL0A) and VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

Permanent TSB Group has higher earnings, but lower revenue than VanEck Bionic Engineering UCITS ETF A Acc. VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Permanent TSB Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Permanent TSB Group£406M0.00£213M£0.43N/A
VanEck Bionic Engineering UCITS ETF A Acc£1.24B0.16N/A-£7.10N/A

In the previous week, Permanent TSB Group's average media sentiment score of 0.00 equaled VanEck Bionic Engineering UCITS ETF A Acc'saverage media sentiment score.

Company Overall Sentiment
Permanent TSB Group Neutral
VanEck Bionic Engineering UCITS ETF A Acc Neutral

5.4% of Permanent TSB Group shares are owned by institutional investors. 79.1% of Permanent TSB Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Permanent TSB Group has a net margin of 54.93% compared to VanEck Bionic Engineering UCITS ETF A Acc's net margin of 0.00%. Permanent TSB Group's return on equity of 10.65% beat VanEck Bionic Engineering UCITS ETF A Acc's return on equity.

Company Net Margins Return on Equity Return on Assets
Permanent TSB Group54.93% 10.65% 0.93%
VanEck Bionic Engineering UCITS ETF A Acc N/A N/A N/A

Summary

Permanent TSB Group beats VanEck Bionic Engineering UCITS ETF A Acc on 7 of the 8 factors compared between the two stocks.

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Finsbury Growth & Income?

Finsbury Growth & Income (LON:FGT) and VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

Finsbury Growth & Income has a net margin of 966.53% compared to VanEck Bionic Engineering UCITS ETF A Acc's net margin of 0.00%. VanEck Bionic Engineering UCITS ETF A Acc's return on equity of 0.00% beat Finsbury Growth & Income's return on equity.

Company Net Margins Return on Equity Return on Assets
Finsbury Growth & Income966.53% -19.34% 4.42%
VanEck Bionic Engineering UCITS ETF A Acc N/A N/A N/A

15.3% of Finsbury Growth & Income shares are held by institutional investors. 0.7% of Finsbury Growth & Income shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Finsbury Growth & Income has higher earnings, but lower revenue than VanEck Bionic Engineering UCITS ETF A Acc. Finsbury Growth & Income is trading at a lower price-to-earnings ratio than VanEck Bionic Engineering UCITS ETF A Acc, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Finsbury Growth & Income-£198.53M-3.98£90.54M-£162.40N/A
VanEck Bionic Engineering UCITS ETF A Acc£1.24B0.16N/A-£7.10N/A

Finsbury Growth & Income pays an annual dividend of GBX 20.20 per share and has a dividend yield of 2.7%. VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. Finsbury Growth & Income pays out -12.4% of its earnings in the form of a dividend. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Finsbury Growth & Income is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Finsbury Growth & Income had 7 more articles in the media than VanEck Bionic Engineering UCITS ETF A Acc. MarketBeat recorded 7 mentions for Finsbury Growth & Income and 0 mentions for VanEck Bionic Engineering UCITS ETF A Acc. Finsbury Growth & Income's average media sentiment score of 1.79 beat VanEck Bionic Engineering UCITS ETF A Acc's score of 0.00 indicating that Finsbury Growth & Income is being referred to more favorably in the media.

Company Overall Sentiment
Finsbury Growth & Income Very Positive
VanEck Bionic Engineering UCITS ETF A Acc Neutral

Summary

Finsbury Growth & Income beats VanEck Bionic Engineering UCITS ETF A Acc on 8 of the 13 factors compared between the two stocks.

How does VanEck Bionic Engineering UCITS ETF A Acc compare to BMO Global Smaller Companies?

BMO Global Smaller Companies (LON:BGSC) and VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

BMO Global Smaller Companies pays an annual dividend of GBX 0.02 per share. VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. BMO Global Smaller Companies pays out 0.0% of its earnings in the form of a dividend. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. VanEck Bionic Engineering UCITS ETF A Acc is clearly the better dividend stock, given its higher yield and lower payout ratio.

Company Net Margins Return on Equity Return on Assets
BMO Global Smaller CompaniesN/A N/A N/A
VanEck Bionic Engineering UCITS ETF A Acc N/A N/A N/A

VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than BMO Global Smaller Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BMO Global Smaller Companies£303.85M0.00N/A£50.70N/A
VanEck Bionic Engineering UCITS ETF A Acc£1.24B0.16N/A-£7.10N/A

In the previous week, BMO Global Smaller Companies' average media sentiment score of 0.00 equaled VanEck Bionic Engineering UCITS ETF A Acc'saverage media sentiment score.

Summary

VanEck Bionic Engineering UCITS ETF A Acc beats BMO Global Smaller Companies on 3 of the 5 factors compared between the two stocks.

Get VanEck Bionic Engineering UCITS ETF A Acc News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYBG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYBG vs. The Competition

MetricVanEck Bionic Engineering UCITS ETF A AccBanks IndustryFinance SectorLON Exchange
Market Cap£199.28M£199.28M£14.10B£2.74B
Dividend Yield2.25%2.25%5.67%6.15%
P/E Ratio-1.96N/A20.59368.96
Price / Sales0.1616.1043.0585,974.72
Price / Cash0.130.1319.4527.87
Price / Book0.040.042.267.75
Net IncomeN/AN/A£1.14B£5.89B
7 Day Performance0.55%0.11%0.64%0.91%
1 Month Performance3.09%0.62%2.41%-0.37%
1 Year Performance-7.87%-1.57%12.00%70.53%

VanEck Bionic Engineering UCITS ETF A Acc Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYBG
VanEck Bionic Engineering UCITS ETF A Acc
N/AGBX 13.89
flat
N/A-7.9%£199.28M£1.24BN/A5,762
CCFS
Charter Court Financial Services Grp
N/AN/AN/AN/A£713.62M£221.10M6.37676
CIHL
Caribbean Investment
N/AN/AN/AN/A£35.27M£29.20M3.08N/A
IL0A
Permanent TSB Group
N/AN/AN/AN/A£12.99M£406M5.532,236
FGT
Finsbury Growth & Income
N/AGBX 739.94
-0.8%
N/A-16.8%£775.16M-£198.53MN/AN/A

Related Companies and Tools


This page (LON:CYBG) was last updated on 7/6/2026 by MarketBeat.com Staff.
From Our Partners